Can I code a patient with type 2 diabetes mellitus and peripheral arterial disease (popliteal pulses 2/4, dorsalis pedis and posterior tibial pulses 1/4 bilaterally) as ICD‑10‑CM (International Classification of Diseases, Tenth Revision, Clinical Modification) E11.51?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

ICD-10-CM E11.51 Coding for Type 2 Diabetes with Peripheral Arterial Disease

Yes, you can code E11.51 (Type 2 diabetes mellitus with peripheral angiopathy without gangrene) for this patient, as the documented pulse examination findings—popliteal 2/4, dorsalis pedis 1/4, and posterior tibial 1/4 bilaterally—constitute clinical evidence of peripheral arterial disease (PAD) in a diabetic patient.

Clinical Justification for PAD Diagnosis

Diminished pedal pulses are diagnostic indicators of PAD in diabetic patients. The European Society of Cardiology guidelines establish that palpation of foot pulses is a cornerstone of PAD screening, and diminished or absent pulsation of the dorsalis pedis artery was documented in 16% of diabetic adults aged 35–54 years and 24% of those aged 55–74 years in population studies 1. Your patient's bilateral 1/4 pulses in both the dorsalis pedis and posterior tibial arteries represent significantly diminished perfusion that meets clinical criteria for PAD 1.

Multiple pulse abnormalities markedly increase the likelihood of confirmed PAD. When both foot arteries (dorsalis pedis and posterior tibial) demonstrate diminished pulses bilaterally, the probability of underlying PAD is substantially elevated 2. The presence of abnormalities at multiple sites—including the popliteal arteries at 2/4—further strengthens the diagnosis 2.

Recommended Confirmatory Testing

While the pulse examination supports the E11.51 diagnosis, objective vascular testing should be performed to confirm PAD and quantify its severity:

  • Measure ankle-brachial index (ABI) bilaterally—an ABI <0.9 confirms PAD, and an ABI <0.8 indicates PAD regardless of symptoms 1. This test is strongly recommended by the European Society of Cardiology for all diabetic patients with diminished pulses 1.

  • Perform handheld Doppler evaluation of both dorsalis pedis and posterior tibial arteries to assess flow signals and waveform quality; absent or monophasic waveforms support the PAD diagnosis 1.

  • If ABI >1.40 (suggesting arterial calcification), obtain a toe-brachial index (TBI), as diabetic patients commonly have non-compressible vessels due to medial arterial calcification 1, 2. A TBI <0.75 indicates PAD 1.

Documentation Requirements for Coding

To support E11.51 coding, your documentation should include:

  • The specific pulse grades at each site (femoral, popliteal, dorsalis pedis, posterior tibial) bilaterally 2
  • Any additional vascular examination findings: skin changes (pallor, dependent rubor, hair loss, dystrophic nails), temperature asymmetry, or non-healing wounds 1, 2
  • Results of objective vascular testing (ABI, Doppler waveforms, or TBI) when available 1
  • Absence of gangrene or tissue necrosis (which would require a different code) 1

Common Coding Pitfalls to Avoid

  • Do not assume palpable pulses exclude PAD in diabetic patients—formal objective testing is required even when pulses are present, as many diabetic patients with PAD have atypical presentations 1, 2.

  • Do not code E11.51 if gangrene or tissue necrosis is present—this requires E11.52 (Type 2 diabetes mellitus with diabetic peripheral angiopathy with gangrene) 1.

  • Do not rely solely on dorsalis pedis pulse assessment—this pulse may be congenitally absent in healthy individuals; absence of the posterior tibial pulse is more specific for PAD 2.

  • Document bilateral findings separately—asymmetric pulse findings may indicate different disease severity between limbs and affect treatment planning 2.

Clinical Implications of This Diagnosis

Patients with type 2 diabetes and PAD require aggressive cardiovascular risk management:

  • LDL-C reduction by ≥50% from baseline with goal <1.4 mmol/L (55 mg/dL) 1
  • Antiplatelet therapy 1
  • Blood pressure control 1
  • Smoking cessation support 1
  • Annual comprehensive foot examination including pulse palpation, sensory testing, and ulcer inspection 2

The coexistence of diabetes and PAD confers nearly 3-fold higher risk of leg amputation compared to either condition alone, and these patients have a 50% mortality rate at 5 years due to systemic atherosclerosis 3. Early diagnosis through proper coding facilitates appropriate specialist referral and intensive risk factor modification 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Systematic Lower Extremity Vascular Examination for Peripheral Artery Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Diabetics with Peripheral Vascular Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What antibiotic is recommended for a 70-year-old female with type 2 diabetes (T2D) and peripheral vascular disease (PVD) who has non-purulent cellulitis of the lower extremity?
What is the best course of management for an asymptomatic elderly patient with violaceous (purple-colored) spots on the foot and friable skin, potentially indicating underlying conditions such as peripheral artery disease (PAD), diabetes mellitus (DM), or nutritional deficiencies?
In a chronic kidney disease stage 5 patient on regular hemodialysis with type 2 diabetes who has an acute lower‑extremity arterial thrombus, what is the safest and most effective anticoagulation and antiplatelet strategy, including heparin management during dialysis?
How should I manage lower‑extremity cellulitis in an adult with diabetes mellitus and possible peripheral arterial disease?
What is the management plan for a patient with worsening left leg pain, history of hypertension and type 2 diabetes, and signs suggestive of severe peripheral arterial disease?
Is lidocaine indicated for managing septic shock, and if a patient with septic shock develops ventricular tachycardia, what is the appropriate dosing and precautions?
What communication strategies and resources are recommended to improve communication with a person with autism spectrum disorder?
What is the appropriate treatment for an elderly male with a urinary tract infection, taking into account renal function, potential complications, and drug safety?
In an older adult with Alzheimer’s disease and agitation refractory to non‑pharmacologic measures and failed or intolerable antipsychotics, which short‑acting benzodiazepine is safest, and what dose and duration should be used?
What is the recommended starting dose and titration schedule of trazodone for insomnia in adults, including older adults and patients with hepatic impairment, and what are the contraindications?
What is the appropriate treatment for an acute anal fissure?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.